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background: Rotational atherectomy (RA) followed by first-generation drug-eluting stent (DES) have favorable result compared with bare-metal 
stent in severe calcified lesion. However, the efficacy of second-generation DES implantation after RA remains unclear.
Methods: Between April 2008 and December 2012, 116 patients (173 lesions) with severe calcified lesions were treated with RA followed by DES 
implantation. These 79 lesions were treated with first-generation DES and 94 lesions were treated with second-generation DES. Angiographic follow-
up was performed at 8 months after procedure. The rates of target lesion revascularization (TLR) and major adverse cardiovascular event (MACE), 
defined as cardiac death, non-fatal myocardial infarction, and TLR were investigated between two groups.
results: Mean follow-up period was 23±16 months. Baseline characteristics were almost similar between two groups. The incidence of binary 
restenosis in first-generation DES (20%) was significantly higher compared to that in second-generation DES (7.3%) (P=0.03). TLR occurred to 7 
patients (13.7%) in first-generation DES and 2 patients (3.1%) in second-generation DES (P=0.035). MACE occurred in 13 patients (25.5%) in first-
generation DES and 10 patients (15.6%) in second-generation DES (P=0.189). In multivariate analysis, the use of first-generation DES (OR 3.86: 
P=0.038) and hemodialysis (OR 8.86: P<0.001) were independent predictors of TLR.
conclusions: RA followed by second-generation DES implantation significantly improved TLR compared with first-generation DES in patients with 
severe calcified lesions.
